PZOO Moves Into The Lucrative Cannabis Space
Good Morning!
PZOO has just muscled into the cannabis space by signing a distribution deal with a leading supplier of vaporizers. The deal gives PZOO access to a growing market for vaping products and according to the company’s release, sales are expected to start in the first week of July (that’s about now-ish).
So what you have is a short term gem that is actively making sales and massively undervalued.
PZOO is trading at .0063. This incidentally is about 693% below the 12 month high which means more upside opportunity for you.
Just make a move on this ASAP… PZOO is a rising tide at the moment.
PZOO Must-See Technicals
PZOO delivered 20% intraday on April 27 after it opened at .0170 before reaching a high of .0204. It’s been in consolidation mode since which means its due for another breakout soon.
PZOO is trading with a 34 RSI suggesting very strong bounce potential from current levels. Keep in mind that momentum is already underway.
PZOO is now a participant in the expected $35 billion cannabis industry. This from a distribution deal recently signed for the sale of vaporisers.
PZOO has strong short-term upside from current levels. The 50 DMA of .010 is 58% above current valuation.
PZOO and its cannabis testing lab subsidiaries and partners are set to benefit from a testing market expected to reach $850 million.
PZOO is experiencing strong daily volatility at the moment. Average volume has now surpassed 8.6 million shares.
About
PZOO (Pazoo, Inc.) is a company focused on health, wellness and safety.
PZOO’s focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through its wholly-owned subsidiary, Harris Lee, and our partnership with MA & Associates, PZOO provides industry-leading laboratory testing of cannabis.
PZOO subsidiaries are currently licensed to test cannabis in Nevada, Oregon and Colorado, with other states to come.
Cannabis Testing Labs – The Sleeping Market Worth Millions
PZOO has a unique opportunity to capitalize on the cannabis testing market. Greenwave Advisors estimate that the market could reach as much as $850 million.
States like Nevada provide some of the biggest opportunities for testing. In fact, Nevada’s Initiative to Regulate and Tax Marijuana explicitly states that, “cultivating, manufacturing, testing, transporting, and selling marijuana will be strictly controlled through state licensing and regulation” and “marijuana sold in the state will be tested and labeled.” These types of regulations promise to create a regulatory-driven market for cannabis testing services.
Big News Development
Pazoo Wholly Owned Subsidiary, CannabisKing Distribution, LLC Signs Deal With Accuvape To Distribute Vaporizers And Related Products
PZOO’s 100% wholly owned subsidiary CannabisKing Distribution, LLC, has signed a deal with Accuvape to sell their vaporizers, related products and services. CannabisKing will mainly focus on selling these products in the jurisdictions where Pazoo's other subsidiaries set up testing labs. However, CannabisKing will not be limited to these jurisdictions and may sell in other parts of the United States.
CannabisKing will begin sales calls by the second week of July and expect to immediately garner orders. This comprehensive product line is state of the art with the best in class support team at Accuvape for support of the end users.
To learn more about PZOO please visit their website: http://pazoo.com/
PZOO has delivered strongly in the past and every short-term indicator suggests it is ready to deliver again.
At just .0063 you really can’t find a cheaper entry into a 58% upside.
Make your move on PZOO now.
